肺腺癌中与表皮生长因子受体外显子19和21突变相关的临床影像学特征
回顾性分析471例手术切除肺腺癌的临床病理与术前胸部CT特征,EGFR突变见于252例(53.5%);联合临床与影像特征预测EGFR突变的AUC为0.784,分别预测外显子19和21突变的AUC为0.807和0.794。
要点
- 小最大径(≤3.9 cm)、非吸烟、微乳头型、胸膜牵拉、血管集束和缺乏实性型是EGFR突变的独立预测因素。
- 非吸烟、血管集束和缺乏实性型是外显子19突变的独立预测因素,AUC为0.807。
- 非吸烟和血管集束是外显子21突变的独立预测因素,AUC为0.794。
核心结论
- 肺腺癌CT影像特征联合临床变量可用于预测EGFR突变状态,分别分析外显子19或21突变可进一步提高诊断效能。
研究设计与样本
- 回顾性研究,纳入471例手术切除的肺腺癌亚洲患者,评估人口学、组织病理学数据和术前胸部CT图像,共评估24个CT描述符,采用单因素分析和多因素逻辑回归分析。
关键影像表现/征象
- 贴壁生长模式在外显子21突变肿瘤中比外显子19突变组更常见(p<0.001)。
- 影像特征包括最大径≤3.9 cm、胸膜牵拉、血管集束和缺乏实性型与EGFR突变相关。
诊断标准与关键数值
- 联合临床和影像特征模型预测EGFR突变的独立预测因素为小最大径(≤3.9 cm)、非吸烟、微乳头型、胸膜牵拉、血管集束和缺乏实性型,AUC为0.784。
- 预测外显子19突变的独立预测因素为非吸烟、血管集束和缺乏实性型,AUC为0.807。
- 预测外显子21突变的独立预测因素为非吸烟和血管集束,AUC为0.794。
临床应用与阅片要点
- 阅片时可关注最大径≤3.9 cm、胸膜牵拉、血管集束、缺乏实性型和贴壁生长模式等特征,结合吸烟史辅助预测EGFR突变状态。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To retrospectively identify clinicopathological and radiological characteristics that could be independent predictors of epidermal growth factor receptor (EGFR) exon 19 and 21 mutation in surgically resected lung adenocarcinomas in a cohort of Asian patients.
MATERIALS AND METHODS: Demographics, histopathology data, and preoperative chest computed tomography (CT) images were evaluated retrospectively in 471 surgically resected lung adenocarcinomas. A total of 24 CT descriptors were assessed. Univariate analyses and multivariate logistic regression analyses were performed to identify independent predicted factors of harbouring EGFR mutations.
RESULTS: EGFR mutations were existed in 252 (53.5%) of 471 patients, and associated with 11 clinicoradiological features. For the model with both clinical and radiological features, the independent predictors of harbouring EGFR mutation were small maximum diameter (≤3.9 cm), non-smokers, micropapillary pattern, pleural retraction, vascular convergence, and absence of solid pattern. The area under the receiver operating characteristic (ROC) curve (AUC) was 0.784. Multivariable logistic regression analysis indicated that non-smokers, vascular convergence, and absence of solid pattern were important independent predictors of EGFR exon 19 mutation, while non-smokers and vascular convergence were independent predictors of EGFR exon 21 mutation. The AUCs were 0.807 and 0.794, respectively. A lepidic growth pattern appeared more frequently in exon 21 mutant tumours than in exon 19 mutant group (p<0.001).
CONCLUSION: CT imaging features of lung adenocarcinomas in combination with clinical variables could be used to prognosticate EGFR mutation status. The separate analysis of EGFR exon 19 or 21 mutation could further improve diagnostic performance.
引用
- Zhao FN, Zhao YQ, Han LZ, et al. Clinicoradiological features associated with epidermal growth factor receptor exon 19 and 21 mutation in lung adenocarcinoma. Clin Radiol. 2018. PMID: 30591175. doi:10.1016/j.crad.2018.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。